Crystalline methamphetamine use and methamphetamine-related harms in Australia

被引:121
|
作者
Degenhardt, Louisa [1 ]
Sara, Grant [2 ]
McKetin, Rebecca [3 ]
Roxburgh, Amanda [1 ]
Dobbins, Timothy [1 ]
Farrell, Michael [1 ]
Burns, Lucinda [1 ]
Hall, Wayne D. [4 ,5 ]
机构
[1] UNSW Australia, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia
[2] Univ Sydney, Sydney Med Sch, Northern Clin Sch, Sydney, NSW, Australia
[3] Curtin Univ, Natl Drug Res Inst, Perth, WA, Australia
[4] Univ Queensland, Ctr Youth Subst Abuse Res, Brisbane, Qld, Australia
[5] Kings Coll London, Inst Psychiat Psychol & Neurosci, Natl Addict Ctr, London, England
基金
英国医学研究理事会;
关键词
methamphetamine; psychosis; dependence; amphetamine-type stimulants; injecting; DRUG-USE; PSYCHOTIC SYMPTOMS; HIV-PREVENTION; HEROIN USERS; DEPENDENCE; TRENDS; ICE; EPIDEMIOLOGY; AMPHETAMINE; PREVALENCE;
D O I
10.1111/dar.12426
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction and AimsConcerns about crystal methamphetamine use and harm have increased in multiple countries. This paper describes how changes in the availability and use of crystal methamphetamine have impacted on methamphetamine-related harms in Australia. Design and MethodsData on methamphetamine use were obtained from population-level surveys, health service data and surveys of drug use among sentinel groups of ecstasy users and people who inject drugs. Data were obtained on seizures, arrests, clandestine laboratory detections, hospital separations, mental health unit admissions, drug telephone helpline calls and drug treatment episodes. Segmented linear regression models were fitted to identify changes in these series using log-transformed data where appropriate. ResultsThe availability of crystal methamphetamine has increased as evidenced by increased laboratory detections, domestic seizures and purity of the seized drug. Population surveys do not report an increase in the number of people who used at least once in the past year. However, more users report using crystal methamphetamine rather than lower-purity powder methamphetamine and more regular use. Indicators of methamphetamine-related harms have increased in parallel with this change. Amphetamine-related helpline calls, drug treatment, arrests and hospital admissions for amphetamine disorders and psychosis all peaked in the mid-2000s, declined for several years and have increased steeply since 2010. Discussion and ConclusionsThe increased availability and use of crystal methamphetamine have been associated with increased regular use and harms. Treatment is required for those experiencing problems and the capacity of health services to provide care needs to be enhanced.[Degenhardt L, Sara G, Connor JP, McKetin R, Roxburgh A, Dobbins T, Farrell M, Burns L, Hall WD. Crystalline methamphetamine use and methamphetamine-related harms in Australia. Drug Alcohol Rev 2017;36:160-170]
引用
收藏
页码:160 / 170
页数:11
相关论文
共 50 条
  • [11] Methamphetamine-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology
    Kaye, Sharlene
    Darke, Shane
    Duflou, Johan
    McKetin, Rebecca
    ADDICTION, 2008, 103 (08) : 1353 - 1360
  • [12] Effects of a methamphetamine vaccine, IXT-v100, on methamphetamine-related behaviors
    Courtney M Keller
    Allyson L Spence
    Misty W Stevens
    S. Michael Owens
    Glenn F Guerin
    Nicholas E Goeders
    Psychopharmacology, 2020, 237 : 655 - 667
  • [13] Populations and areas most at risk of methamphetamine-related harms: A commentary on Degenhardt et al.
    Woods, Cindy
    Usher, Kim
    DRUG AND ALCOHOL REVIEW, 2017, 36 (04) : E5 - E6
  • [14] Effects of a methamphetamine vaccine, IXT-v100, on methamphetamine-related behaviors
    Keller, Courtney M.
    Spence, Allyson L.
    Stevens, Misty W.
    Owens, S. Michael
    Guerin, Glenn F.
    Goeder, Nicholas E. s
    PSYCHOPHARMACOLOGY, 2020, 237 (03) : 655 - 667
  • [15] Candidate gene analysis of methamphetamine-related disorders
    Ujike, H
    Inada, T
    Harano, M
    Komiyama, T
    Yamada, M
    Sekine, Y
    Iwata, N
    Iyo, M
    Sora, I
    Ozaki, N
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S24 - S25
  • [16] Methamphetamine-related emergency department utilization and cost
    Hendrickson, Robert G.
    Cloutier, Robert
    McConnell, K. John
    ACADEMIC EMERGENCY MEDICINE, 2008, 15 (01) : 23 - 31
  • [17] Trends in methamphetamine use, markets and harms in Australia, 2003-2019
    Man, Nicola
    Sisson, Scott A.
    McKetin, Rebecca
    Chrzanowska, Agata
    Bruno, Raimondo
    Dietze, Paul M.
    Price, Olivia
    Degenhardt, Louisa
    Gibbs, Daisy
    Salom, Caroline
    Peacock, Amy
    DRUG AND ALCOHOL REVIEW, 2022, 41 (05) : 1041 - 1052
  • [18] Methamphetamine-related psychosis: an opportunity for assertive intervention and prevention
    Lappin, Julia M.
    Sara, Grant E.
    Farrell, Michael
    ADDICTION, 2017, 112 (06) : 927 - +
  • [19] Fentanyl and other opioid involvement in methamphetamine-related deaths
    Dai, Zheng
    Abate, Marie A.
    Groth, Caroline P.
    Rucker, Tori
    Kraner, James C.
    Mock, Allen R.
    Smith, Gordon S.
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2022, 48 (02): : 226 - 234
  • [20] The relationship between crystalline methamphetamine use and methamphetamine dependence
    McKetin, Rebecca
    Kelly, Erin
    McLaren, Jennifer
    DRUG AND ALCOHOL DEPENDENCE, 2006, 85 (03) : 198 - 204